The results showed that free exatecan was mainly observed in the livers and spleens with low tumor accumulation, whereas Mal-azo-Exatecan accumulated within tumor tissues 3.4-fold highly via efficient in situ albumin-binding (Figure 6C). This evidence concerns the gene ALB and neoplasm.